Singkham Noppaket, Wongsalap Yuttana, Poolpun Duangkamon, Phetnoo Sirichok, Somkhon Chuthalak
Division of Pharmacy Practice, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.
Unit of Excellence on Pharmacogenomic Pharmacokinetic and Pharmacotherapeutic Researches (UPPER), School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.
Ann Geriatr Med Res. 2021 Dec;25(4):260-268. doi: 10.4235/agmr.21.0098. Epub 2021 Dec 16.
Digoxin is used to control heart rate in patients with heart failure (HF) and atrial fibrillation (AF). However, its use is often limited in older patients, as they are prone to digoxin toxicity. This study aimed to determine the prevalence of digoxin use, investigate the factors associated with digoxin use, and explore the association between digoxin use and clinical outcomes in older Thai patients with HF and AF.
This cross-sectional study used data obtained from an electronic medical records database. We performed logistic regression analysis to determine the prevalence of digoxin use at index discharge and the factors associated with its use. The Cox proportional hazard model was used to determine the association of all-cause mortality and HF rehospitalization with digoxin use.
Of the 640 patients assessed, 107 (16.72%) were prescribed digoxin before discharge. The factors negatively associated with digoxin use included high serum creatinine level (adjusted odds ratio [AOR] =0.38; 95% confidence interval [CI], 0.22-0.65) and ischemic heart disease (IHD) (AOR=0.52; 95% CI, 0.30-0.88). The factors positively associated with digoxin use were the use of diuretics (AOR=2.65; 95% CI, 1.60-4.38) and mineralocorticoid receptor antagonists (MRAs) (AOR=2.24; 95% CI, 1.18-4.27). We observed no significant association between digoxin use and clinical outcomes (adjusted hazard ratio=1.00; 95% CI, 0.77-1.30).
Digoxin use was prevalent among older patients with HF and AF. Patients with high serum creatinine or IHD were less likely to be prescribed digoxin, whereas those using diuretics or MRAs were more likely to be prescribed digoxin. Although digoxin use was not uncommon among older patients, it was prescribed with caution among Thai patients hospitalized with HF and AF.
地高辛用于控制心力衰竭(HF)和心房颤动(AF)患者的心率。然而,在老年患者中其使用常常受到限制,因为他们容易发生地高辛中毒。本研究旨在确定地高辛的使用 prevalence,调查与地高辛使用相关的因素,并探讨地高辛使用与泰国老年HF和AF患者临床结局之间的关联。
这项横断面研究使用了从电子病历数据库中获得的数据。我们进行逻辑回归分析以确定出院时地高辛的使用 prevalence 及其使用相关因素。Cox 比例风险模型用于确定全因死亡率和HF再住院与地高辛使用之间的关联。
在评估的640例患者中,107例(16.72%)在出院前被开具了地高辛。与地高辛使用呈负相关的因素包括高血清肌酐水平(调整优势比[AOR]=0.38;95%置信区间[CI],0.22 - 0.65)和缺血性心脏病(IHD)(AOR = 0.52;95% CI,0.30 - 0.88)。与地高辛使用呈正相关的因素是利尿剂的使用(AOR = 2.65;95% CI,1.60 - 4.38)和盐皮质激素受体拮抗剂(MRAs)的使用(AOR = 2.24;95% CI,1.18 - 4.27)。我们观察到地高辛使用与临床结局之间无显著关联(调整风险比 = 1.00;95% CI,0.77 - 1.30)。
地高辛在老年HF和AF患者中使用普遍。血清肌酐高或患有IHD的患者开具地高辛的可能性较小,而使用利尿剂或MRAs的患者开具地高辛的可能性较大。尽管地高辛在老年患者中使用并不罕见,但在因HF和AF住院的泰国患者中开具时需谨慎。